Food and Drug Law Institute to Hold Historic Conference on U.S.-China Food and Drug Law

Dec 15, 2010, 08:00 ET from Food and Drug Law Institute

Top U.S. and Chinese Government Officials Expected to Speak at June 13-14, 2011 Meeting in Beijing

WASHINGTON, Dec. 15, 2010 /PRNewswire-USNewswire/ -- On June 13-14, 2011, in Beijing, China, the Food and Drug Law Institute (FDLI) will host a historic conference on food and drug law, regulation and policy in China and the United States.

Top officials from China, including Shao Mingli, Commissioner, State Food and Drug Administration, Ambassador Zhang Yesui, Chinese Ambassador to the United States, have been invited to speak at the meeting. Several U.S. government officials are expected to make major presentations at the conference, U.S.-China Food and Drug Law: Ensuring Quality, Improving Safety, Expanding Access, including:

  • Margaret Hamburg, Commissioner, Food and Drugs, U.S. Food and Drug Administration (tentative acceptance)
  • Ralph Tyler, Chief Counsel, U.S. Food and Drug Administration
  • U.S. Senator Orrin Hatch (R-UT) (invited)
  • U.S. Representative Joseph Baca (D-CA) (invited)
  • Ambassador Jon Huntsman, Jr., U.S. Ambassador to China (invited)

The conference will focus on business opportunities and policy challenges in ensuring safety and promoting health for the combined U.S./China market of more than 1.6 billion consumers. More than 150 food, pharmaceutical, device, biologics, and dietary supplement manufacturers, practicing attorneys, governments officials, venture capitalists, academics and consultants are expected to attend this groundbreaking conference.

"China is destined to become an incredibly vital player in the food and drug law, regulation, policy and business community," said Minnie Baylor-Henry, chair of FDLI's Board of Directors. "With its long history of providing educational programs to all sectors of this community, FDLI is uniquely positioned to hold this landmark meeting."

The program includes sessions on ensuring the quality and integrity of the global supply chain, consumer protection, enforcement, and post-market surveillance.

The first day will include an interactive roundtable discussion about the myths and realities of doing business in China.  Experts from China, the United States, multinational companies and consultants will provide insider perspectives on successful manufacturing, partnering and marketing practices in China. The second day of the meeting will include a luncheon presentation on the critical issue of global harmonization.

FDLI is hosting the conference in cooperation with Tsinghua University School of Law and Health Law Research Center.

Sponsoring organizations for the event include:  

  • Arnold & Porter LLP
  • BD;
  • Becker & Associates Consulting, Inc.
  • Boston Scientific Corporation
  • Butler, Snow, O'Mara, Stevens & Canada, PLLC
  • Covington & Burling LLP
  • Duane Morris LLP
  • Johnson & Johnson
  • Kelley Drye & Warren LLP
  • Novartis
  • Ropes & Gray LLP
  • U.S. Pharmacopeia

To view the program agenda, register for the conference or find out about sponsorship opportunities, visit http://www.fdli.org/china

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. FDLI's scope includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

SOURCE Food and Drug Law Institute



RELATED LINKS

http://www.fdli.org